Pfizer bivalent vaccine reduces Covid-related death risk by 68 per cent in older people: Study
Israel has prioritised bivalent mRNA booster vaccines for people at high risk of severe COVID-19, primarily those aged 65 years or older. NEW DELHI: Vulnerable people aged 65 years and over receiving the Pfizer bivalent mRNA vaccine booster…